Peer review reports
From: Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study
Original Submission |
29 Mar 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
12 May 2021 |
Reviewed |
Reviewer Report
|
18 May 2021 |
Reviewed |
Reviewer Report
|
16 Jul 2021 |
Author responded |
Author comments - Jiaming Qian
|
Resubmission - Version 6 |
16 Jul 2021 |
Submitted |
Manuscript version 6
|
2 Aug 2021 |
Author responded |
Author comments - Jiaming Qian
|
Resubmission - Version 7 |
2 Aug 2021 |
Submitted |
Manuscript version 7
|
13 Aug 2021 |
Author responded |
Author comments - Jiaming Qian
|
Resubmission - Version 8 |
13 Aug 2021 |
Submitted |
Manuscript version 8
|
22 Aug 2021 |
Reviewed |
Reviewer Report
|
15 Nov 2021 |
Author responded |
Author comments - Jiaming Qian
|
Resubmission - Version 9 |
15 Nov 2021 |
Submitted |
Manuscript version 9
|
Publishing |
10 Dec 2021 |
Editorially accepted |
|
4 Feb 2022 |
Article published |
10.1186/s12876-021-02074-z
|
Learn about peer review